Chagas disease
- PMID: 28673423
- DOI: 10.1016/S0140-6736(17)31612-4
Chagas disease
Abstract
Chagas disease is an anthropozoonosis from the American continent that has spread from its original boundaries through migration. It is caused by the protozoan Trypanosoma cruzi, which was identified in the first decade of the 20th century. Once acute infection resolves, patients can develop chronic disease, which in up to 30-40% of cases is characterised by cardiomyopathy, arrhythmias, megaviscera, and, more rarely, polyneuropathy and stroke. Even after more than a century, many challenges remain unresolved, since epidemiological control and diagnostic, therapeutic, and prognostic methods must be improved. In particular, the efficacy and tolerability profile of therapeutic agents is far from ideal. Furthermore, the population affected is older and more complex (eg, immunosuppressed patients and patients with cancer). Nevertheless, in recent years, our knowledge of Chagas disease has expanded, and the international networking needed to change the course of this deadly disease during the 21st century has begun.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Comment in
-
Chagas disease cardiomyopathy treatment remains a challenge - Authors' reply.Lancet. 2018 Jun 2;391(10136):2209-2210. doi: 10.1016/S0140-6736(18)30776-1. Epub 2018 Jun 1. Lancet. 2018. PMID: 29893217 No abstract available.
-
Chagas disease cardiomyopathy treatment remains a challenge.Lancet. 2018 Jun 2;391(10136):2209. doi: 10.1016/S0140-6736(18)30751-7. Epub 2018 Jun 1. Lancet. 2018. PMID: 29893218 No abstract available.
Similar articles
-
Old and new challenges in Chagas disease.Lancet Infect Dis. 2015 Nov;15(11):1347-56. doi: 10.1016/S1473-3099(15)00243-1. Epub 2015 Jul 28. Lancet Infect Dis. 2015. PMID: 26231478
-
Chagas Heart Disease: An Update.Am J Med. 2015 Nov;128(11):1251.e7-9. doi: 10.1016/j.amjmed.2015.04.036. Epub 2015 Jun 4. Am J Med. 2015. PMID: 26052027 Review.
-
Chagas disease.Lancet. 2010 Apr 17;375(9723):1388-402. doi: 10.1016/S0140-6736(10)60061-X. Lancet. 2010. PMID: 20399979 Review.
-
[Diagnosis and treatment of Chagas disease].Enferm Infecc Microbiol Clin. 2013 Feb;31 Suppl 1:26-34. doi: 10.1016/S0213-005X(13)70111-3. Enferm Infecc Microbiol Clin. 2013. PMID: 23453228 Spanish.
-
Challenges in the management of Chagas disease in Latin-American migrants in Europe.Clin Microbiol Infect. 2017 May;23(5):290-295. doi: 10.1016/j.cmi.2017.04.013. Epub 2017 Apr 17. Clin Microbiol Infect. 2017. PMID: 28428122 Review.
Cited by
-
Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: an updated systematic review and meta-analysis.Lancet Reg Health Eur. 2024 Sep 6;46:101040. doi: 10.1016/j.lanepe.2024.101040. eCollection 2024 Nov. Lancet Reg Health Eur. 2024. PMID: 39290806 Free PMC article.
-
Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain.Molecules. 2024 Sep 5;29(17):4224. doi: 10.3390/molecules29174224. Molecules. 2024. PMID: 39275072 Free PMC article.
-
Cyclodextrin Complexes for the Treatment of Chagas Disease: A Literature Review.Int J Mol Sci. 2024 Sep 1;25(17):9511. doi: 10.3390/ijms25179511. Int J Mol Sci. 2024. PMID: 39273458 Free PMC article. Review.
-
Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas disease.Immun Inflamm Dis. 2024 Sep;12(9):e1330. doi: 10.1002/iid3.1330. Immun Inflamm Dis. 2024. PMID: 39267468 Free PMC article.
-
Prevention of congenital chagas disease by trypanocide treatment in women of reproductive age: A meta-analysis of observational studies.PLoS Negl Trop Dis. 2024 Sep 5;18(9):e0012407. doi: 10.1371/journal.pntd.0012407. eCollection 2024 Sep. PLoS Negl Trop Dis. 2024. PMID: 39236037 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical